BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loras A, Martínez-Bisbal MC, Quintás G, Gil S, Martínez-Máñez R, Ruiz-Cerdá JL. Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer. Cancers (Basel) 2019;11:E914. [PMID: 31261883 DOI: 10.3390/cancers11070914] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhuang J, Yang X, Zheng Q, Li K, Cai L, Yu H, Lv J, Bai K, Cao Q, Li P, Yang H, Wang J, Lu Q. Metabolic Profiling of Bladder Cancer Patients' Serum Reveals Their Sensitivity to Neoadjuvant Chemotherapy. Metabolites 2022;12:558. [PMID: 35736490 DOI: 10.3390/metabo12060558] [Reference Citation Analysis]
2 Tsamouri MM, Durbin-johnson BP, Culp WTN, Palm CA, Parikh M, Kent MS, Ghosh PM. Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs. Metabolites 2022;12:200. [DOI: 10.3390/metabo12030200] [Reference Citation Analysis]
3 Li M, Guo Z, Zheng X, Yang H, Feng W, Kong J. An electrochemical aptasensor based on eATRP amplification for the detection of bisphenol A. Analyst 2019;144:5691-9. [PMID: 31508622 DOI: 10.1039/c9an01266d] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
4 Jacyna J, Kordalewska M, Artymowicz M, Markuszewski M, Matuszewski M, Markuszewski MJ. Pre- and Post-Resection Urine Metabolic Profiles of Bladder Cancer Patients: Results of Preliminary Studies on Time Series Metabolomics Analysis. Cancers 2022;14:1210. [DOI: 10.3390/cancers14051210] [Reference Citation Analysis]
5 Juang HH, Chen SM, Lin G, Chiang MH, Hou CP, Lin YH, Yang PS, Chang PL, Chen CL, Lin KY, Tsui KH. The Clinical Experiences of Urine Metabolomics of Genitourinary Urothelial Cancer in a Tertiary Hospital in Taiwan. Front Oncol 2021;11:680910. [PMID: 34395249 DOI: 10.3389/fonc.2021.680910] [Reference Citation Analysis]
6 Novak D, Utikal J. New Biomarkers in Cancers. Cancers (Basel) 2021;13:708. [PMID: 33572354 DOI: 10.3390/cancers13040708] [Reference Citation Analysis]
7 Loras A, Segovia C, Ruiz-Cerdá JL. Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer. Cancers (Basel) 2021;13:2719. [PMID: 34072826 DOI: 10.3390/cancers13112719] [Reference Citation Analysis]
8 Zhao J, Xu L, Dong Z, Zhang Y, Cao J, Yao J, Xing J. The LncRNA DUXAP10 Could Function as a Promising Oncogene in Human Cancer. Front Cell Dev Biol 2022;10:832388. [DOI: 10.3389/fcell.2022.832388] [Reference Citation Analysis]
9 Ahmed N, Kidane B, Wang L, Nugent Z, Moldovan N, McElrea A, Shariati-Ievari S, Qing G, Tan L, Buduhan G, Srinathan SK, Meyers R, Aliani M. Metabolic Alterations in Sputum and Exhaled Breath Condensate of Early Stage Non-Small Cell Lung Cancer Patients After Surgical Resection: A Pilot Study. Front Oncol 2022;12:874964. [PMID: 35719971 DOI: 10.3389/fonc.2022.874964] [Reference Citation Analysis]
10 Petrella G, Ciufolini G, Vago R, Cicero DO. Urinary Metabolic Markers of Bladder Cancer: A Reflection of the Tumor or the Response of the Body? Metabolites 2021;11:756. [PMID: 34822414 DOI: 10.3390/metabo11110756] [Reference Citation Analysis]